Biotechnology - Agios Pharmaceuticals

Filter

Current filters:

Agios Pharmaceuticals

Popular Filters

Celgene exercises option for Agios Pharma’s AG-221

Celgene exercises option for Agios Pharma’s AG-221

17-06-2014

Metabolism specialist Agios Pharmaceuticals says that its partner, biotech major Celgene Corp, has exercised…

AG-221Agios PharmaceuticalsBiotechnologyCelgeneLicensingOncologyRegulationResearchUSA

Agios extends cancer metabolism accord with Celgene

Agios extends cancer metabolism accord with Celgene

12-12-2013

Metabolism specialist Agios Pharmaceuticals has announced an extension of one additional year to the…

Agios PharmaceuticalsBiotechnologyCelgeneLicensingOncologyResearch

COMPANY SPOTLIGHT

Menarini

Back to top